Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

  1. Schramm, A.
  2. Schowe, B.
  3. Fielitz, K.
  4. Heilmann, M.
  5. Martin, M.
  6. Marschall, T.
  7. Köster, J.
  8. Vandesompele, J.
  9. Vermeulen, J.
  10. De Preter, K.
  11. Koster, J.
  12. Versteeg, R.
  13. Noguera, R.
  14. Speleman, F.
  15. Rahmann, S.
  16. Eggert, A.
  17. Morik, K.
  18. Schulte, J.H.
Revue:
British Journal of Cancer

ISSN: 0007-0920,  1532-1827

Année de publication: 2012

Volumen: 107

Número: 8

Pages: 1409-1417

Type: Article

DOI: 10.1038/BJC.2012.391 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus